ArticleFrontiers in oncology2022

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.

Axel Muendlein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.